Brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-related kinase B (TrkB) are widely expressed in the vertebrate nervous system and play a central role in mature neuronal function.
Introduction
BDNF is a member of the neurotrophin family of growth factors and promotes neuron survival by activating the receptor tyrosine kinase TrkB (1) . BDNF is secreted in an activity-dependent manner (2) and has been shown to play a critical role in synaptogenesis (3) , dendrite growth (4, 5) , synaptic plasticity (6, 7) , learning (8) and in the acquisition of other differentiated features of neurons (9, 10) .
Exogenously provided BDNF can protect neurons from insults relevant to neurological diseases (11) (12) (13) (14) and raising the possibility that it may have potential as a therapeutic agent in humans.
In addition to its undisputed beneficial actions on neurons, several groups have shown that BDNF-TrkB signaling in vitro can render neurons vulnerable to insults. Administration of BDNF to cortical neuron cultures increases cell death evoked by oxygen-glucose deprivation (15) , nitric oxide toxicity (16) and insults relevant to amyotrophic lateral sclerosis (ALS) (17) (18) (19) . TrkB forms a receptor for BDNF as part of a hetero-dimeric complex with p75 and ligand binding to p75 has been shown to induce cell death (20, 21) . This raises the possibility that BDNF renders neurons vulnerable to insults by binding to p75.
While a variety of in vitro studies support this contention (22) (23) (24) , placing the mutant G93A mutant SOD1 mouse (a commonly employed mouse model of familial ALS) on the p75 -/background has only modest beneficial effects (25, 26) . There is evidence favoring the view that activation of TrkB by BDNF can render neurons vulnerable to insults: 1) cortical neuron cultures from TrkB -/mice resist the toxic actions of BDNF (27) and 2) when grown in a cocktail of trophic factors including BDNF, pharmacological inhibition of TrkB activation protects against insults (17) . The relevance of these in vitro observations to animals is entirely unknown.
In the present study we examined the in vivo role of TrkB expression by adult motor neurons in mutant SOD1-induced motor neuron disease. We find that elimination of TrkB from a subpopulation of adult motor neurons and segmental spinal cord interneurons has beneficial effects on animal survival and locomotor/strength function. These beneficial effects are due to preservation of motor neurons and the neuromuscular junctions in mutant SOD1 expressing animals with motor neurons lacking TrkB.
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Results
Cre-mediated recombination of TrkB in spinal cord motor neurons and interneurons
We use the Cre-LoxP system to eliminate TrkB from motor neurons. To avoid developmental effects that could complicate interpretation of these experiments, we chose a Cre driver line in which recombination begins around the first month of postnatal life. The vesicular acetylcholine transporter (VAChT) promoter driving Cre expression has been used previously to disable LoxP flanked genes specifically in motor neurons (28) . Using the ROSA 26 reporter line, we confirmed that VAChT-Cremedicated recombination begins at around 4 weeks of age and reaches its maximum by 6 months of age ( Fig. 1A) . Based on size, shape and location, it appears that Cre-mediated recombination is occurring mostly in motor neurons (approximately 50% of all motor neurons) (29) but also a small population of interneurons. The LoxP flanked TrkB allele has been shown to readily undergo recombination (30) . We chose the G85R mutant SOD1 mice for study because in this mouse strain, the first pathological features are identified at six months of age (31) . Thus, motor neuron development is likely to be normal in the G85R-SOD1 +/-;TrkB LoxP/LoxP ;VAChT-Cre +/mice and any effects of TrkB signaling in mature motor neurons of mice expressing mutant SOD1 could be assessed. Through a 5-step breeding strategy (see Material and Methods), we generated mice in our prime comparison groups with genotypes: G85R-SOD1 +/-;TrkB LoxP/LoxP ;VAChT-Cre +/-(deleted TrkB in motor neurons from mutant SOD1 mice) or G85R-SOD1 +/-;TrkB LoxP/LoxP ;VAChT-Cre -/-(intact TrkB in motor neurons from mutant SOD1 mice). Prior to generation of tri-genic mice, each primary strain was backcrossed into the C57BL/6 background at least five generations. All animals discussed from this point forward are homozygous for the floxed TrkB allele (TrkB LoxP/LoxP ). In light of this, unless otherwise specified, we will simplify the notation of the genetic background of the mice we studied by eliding this piece of data. Thus, in this short hand, G85R-SOD1 +/-;VAChT-Cre +/mice have the genotype G85R-SOD1 +/-;TrkB LoxP/LoxP ;VAChT-Cre +/-. Each LoxP flanked gene undergoes Cre-mediated recombination with variable efficiency, and effect likely related to chromatin structure. To show that TrkB was eliminated from motor neurons in G85R-SOD1 +/-;VAChT-Cre +/mice, we began with immunological approaches. None of the antibodies we used provided high quality images in immunological assays. Immunoblots for TrkB using spinal cord lysates from G85R-SOD1 +/-;VAChT-Cre +/versus G85R-SOD1 +/-;VAChT-Cre -/animals were indistinguishable and this is likely to be due to TrkB expression in non-Cre expressing cells in the TrkB LoxP/LoxP mice. Given these problems, we turned to laser capture microscopy. We dissected by guest on April 29, 2016 http://hmg.oxfordjournals.org/ Downloaded from individual large neurons in the ventral horn (putative motor neurons) from frozen sections of eight-monthold G85R-SOD1 +/-;VAChT-Cre +/mice using a laser microdissector ( Fig. 1B-D) . We extracted RNA from lysates of each dissected neuron and performed RT-PCR and nested PCR for TrkB, Cre and choline acetyltransferase (ChAT, a biosynthetic enzyme enriched in motor neurons) ( Fig. 1E) .
Among 99 specimens examined, sixteen specimens were ChAT-positive, Cre-positive and TrkBnegative ( Fig. 1E , lanes 1, 3, 12 & 15; 1F), and these cells probably represent motor neurons (expressing ChAT) in which TrkB expression is eliminated when Cre recombinase is expressed. Twelve specimens were ChAT-positive, Cre-positive and TrkB-positive (Fig. 1E , lane 2; 1F) and these cells probably represent motor neurons in which TrkB is expressed even though Cre is also expressed. Eight specimens were ChAT-positive, Cre-negative and TrkB-negative ( Fig. 1F ) and these cells probably represent motor neurons in which neither TrkB nor Cre is expressed. Finally, fourteen neurons were ChAT-positive, Crenegative and TrkB-positive and these neurons probably represent motor neurons that express TrkB when Cre is lacking (Fig. 1E, Twenty-six specimens were ChAT-negative (putative non-motor neurons) but positive for Cre and/or TrkB. Among them seven cells were ChAT-negative, Cre-positive and TrkB-negative ( Fig. 1E, lanes16, 17 & 19) , eight cells were ChAT-negative, Cre-positive and TrkB-positive ( Fig. 1E , lanes 10), and eleven cells were ChAT-negative, Cre-negative and TrkB-positive ( Fig. 1E , lanes 5 & 8) . We suggest that these specimens are derived from interneurons and that TrkB undergoes Cre-mediated recombination in the presence of Cre recombinase albeit with less than perfect efficiency. We did not detected expression of ChAT, Cre recombinase and TrkB in other twenty-three specimens (Fig. 1E , lanes 6
Elimination of TrkB increases life span, slows disease progression and improves locomotor function in G85R SOD1 mice
We began by assessing survival and health of mice with a single genetic manipulation (ie VAChT-Cre +/or TrkB LoxP/LoxP ) or mice with two genetic manipulations (VAChT-Cre +/-;TrkB LoxP/LoxP ). Both the uni-and bi-genic mice strains lived at least for 18 months without evidence for an adverse effect on health monitored as normal weight gain, fecundity and activity levels (data not shown). We next turned to the trigenic mice. Male G85R-SOD1 +/-;VAChT-Cre +/mice lived an average 26 days longer than male G85R-SOD1 +/-;VAChT-Cre -/mice (3847 (n=15) versus 3588 days (n=15), p=0.033, Fig. 2A ). Female G85R-SOD1 +/-;VAChT-Cre +/mice lived an average of 28 days longer than female G85R-SOD1 +/-;VAChT-Cre -/-(3637 days (n=21) versus 3359 days (n=14), p=0.037, Fig. 2B ). Thus conditional deletion of TrkB from adult motor neurons, and a subpopulation of adjacent interneurons, is associated with lifespan extension of mutant SOD mice of both sexes. For the remainder of this report we focus on male mutant SOD1 mice.
We monitored body weight of four groups of male animals: (1) G85R-SOD1 -/-;VAChT-Cre -/-, (2) G85R-SOD1 -/-;VAChT-Cre +/-, (3) G85R-SOD1 +/-;VAChT-Cre -/-, and (4) G85R-SOD1 +/-;VAChT-Cre +/-( Fig. 2C) . By ANOVA, we found no group differences at 46, 48, 50 or 52 weeks of life. Group differences were observed at week 54 (F (3, 26) =3.888, p=0.02) and at week 56 (F (3.25) =5.871, p=0.0035).
At week 54, all mouse groups in which G85R SOD1 was expressed were significantly lighter than mice that did not express G85R SOD1 (post hoc analysis with significance set at p<0.05). The same was true at week 56 time point. It is noteworthy that no statistically significant difference in weight was seen between G85R-SOD1 +/-;VAChT-Cre -/and G85R-SOD1 +/-;VAChT-Cre +/mice.
The onset of disease has been defined by the peak of bodyweight curve (32) , and the early phase of the clinical motor neuron disease has been defined as the time from peak of bodyweight to 10% weight loss (33) . Previous work suggests that events occurring within motor neurons themselves underlie the "initiation phase" of mutant SOD1 disease (33) . We next compared the disease onset and progression between male G85R-SOD1 +/-;VAChT-Cre +/mice and G85R-SOD1 +/-;VAChT-Cre -/mice (n=12 in each group). When we analyzed our data this way, we found that these two groups mice had similar disease onset (30810 versus 3066 days, G85R-SOD1 +/-;VAChT-Cre +/and G85R-SOD1 +/-;VAChT-Cre -/respectively, p=0.460, Fig. 2D ). On the other hand, the early phase of the disease was 19 days longer in 7 the G85R-SOD1 +/-;VAChT-Cre +/mice versus the G85R-SOD1 +/-;VAChT-Cre -/mice (3586 versus 3397 days, p=0.027, Fig. 2E-F) . We also monitored the onset of paralysis by measuring grip strength.
We found that the cumulative probability of onset of paralysis, as defined by 30% decline of either forelimb or hindlimb grip strength, was significantly delayed by 21 days in G85R-SOD1 +/-;VAChT-Cre +/mice in comparison with the G85R-SOD1 +/-;VAChT-Cre -/mice (3617 versus 3406 days, p=0.037, Fig.   2G ). Finally we evaluated locomotor function using the accelerating rotarod test. When assessed at peak bodyweight, G85R-SOD1 +/-;VAChT-Cre +/mice stayed on the device significantly longer than the G85R-SOD1 +/-;VAChT-Cre -/mice (27219 versus 19727 seconds, p=0.035, Fig. 2H ). We also assessed locomotor function 2 weeks after peak of bodyweight and again found that, G85R-SOD1 +/-;VAChT-Cre +/mice stayed on the device significantly longer than the G85R-SOD1 +/-;VAChT-Cre -/mice (24625 versus 17924 seconds, p=0.033, Fig. 2I ). Together these observations indicate that the early phase of mutant SOD1 disease is more prolonged and milder in mice with the conditional deletion of TrkB. These observations are consistent with the notion that activation of TrkB regulates biological processes within motor neurons themselves that play a crucial role in the earliest phases of clinical mutant SOD1 disease.
Deletion of TrkB reduces the formation of mutant SOD1 inclusions and ubiquitination in G85R SOD1 mice
The presence of SOD1 immunoreactive inclusions in neuronal cell bodies and processes had been shown as early hallmarks of disease in G85R transgenic mice (31) . We next compared the development of SOD1 aggregation in G85R-SOD1 +/-;VAChT-Cre +/and G85R-SOD1 +/-;VAChT-Cre -/mice. We found that prior to clinical onset, intense and diffusely localized human SOD1 immunoreactivity were seen in cell bodies of ventral motor neurons of both G85R-SOD1 +/-;VAChT-Cre +/and G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 3A-B , arrows). At this stage, more neuronal processes showing intense immunoreactivity to human SOD1 were seen in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 3A , arrowheads) than in G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 3B) . As disease progresses, prominent neuronal processes with intense human SOD1 immunoreactivity increased in abundance in the ventral area of G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 3C&E , arrowheads) and G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 3D&F, arrowheads) .
Western blot analysis showed similar expression level of human SOD1 in Triton-soluble supernatant of spinal cord lysates from presymptomatic G85R-SOD1 +/-;VAChT-Cre -/and G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 3G) . However, more G85R SOD1 was found in Triton-insoluble pellet in G85R-SOD1 +/-; VAChT-Cre -/mice than in G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 3H ), suggesting that conditional deletion of TrkB decreases aggregation of mutant SOD1 in early stage of mutant SOD1 disease.
Another pathological hallmark of ALS is the presence of ubiquitinated inclusions in the perikaryon and proximal axons of surviving spinal motor neurons (34). Next we set out to assess the effects of elimination of motor neuron TrkB on deposition of ubiquitinated proteins in spinal motor neurons. Immunohistochemical staining of lumbar spinal cord sections from mice at different disease stages with ubiquitin antibodies showed that G85R-SOD1 -/-;VAChT-Cre -/and G85R-SOD1 -/-;VAChT-Cre +/control mice had diffuse distribution of ubiquitin immunoreactivity in motor neurons at all ages examined ( Fig. 4A-C 
Elimination of TrkB in motor neurons reduces inflammation in G85R SOD1 mice
A number of potential processes could count for the effects of conditional deletion of TrkB on the early phase of mutant SOD1 disease. The cell non-autonomous features of mutant SOD1 induced motor neuron disease have received increasing attention recently. During the clinically manifest phase of the disease, reactive astrocytosis and inflammatory responses are evident. Does the elimination of TrkB from motor neurons influence these cellular responses? To assess this, we immunohistologically examined spinal cords from mice in presymptomatic phase (8-month-old), symptomatic (11-month-old) and end stage of disease for glial fibrillary astrocytic protein (GFAP-a marker for reactive astrocytosis) as an indicator of astroglial response. In both the presymptomatic as well as symptomatic phase of the disease, the G85R-SOD1 +/-;VAChT-Cre +/mice displayed significantly less GFAP-immunopositive astrocytes in the spinal cord compared to G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 5A -C, p=0.0062; Fig. 5D -F, 9 from presymptomatic 8-month-old mice further showed higher expression level of GFAP in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 5I) .
We used immunoreactivity against ionized calcium-binding adaptor molecule (Iba)-1, a specific marker for activated microglial cells, to detect microglia in spinal cord. We found that the numbers of Iba1-immunopositive cells were significantly decreased in spinal cords of presymptomatic (8-month-old) ( Fig. 6B-C, p=0 .009) and symptomatic G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 6E-F , p=0.016) compared to G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 6A, D) . In agreement with this observation, western blot analysis of presymptomatic spinal cord lysates showed lower expression level of Iba1 in G85R-SOD1 +/-;VAChT-Cre +/mice compared with G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 6I) . This result probably indicates that mutant SOD1 expressing motor neurons that lack TrkB survive longer than those that express TrkB and as a by product of this, cellular responses within the spinal cord parenchyma to damaged motor neurons are delayed.
Elimination of TrkB delays motor axon degeneration in G85R SOD1 mice
To assess the effects of these manipulations on progression of ventral motor neuron axonal degeneration, we examined and counted axons in the L5 ventral roots. At the 11-month time point, we found obvious loss of axons and degenerating profiles in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 7C ) in comparison with control groups (Fig. 7A-B) . The predominant degenerative features were increased interaxonal space, presence of macrophages and greater variation in axon size (Fig. 7C) . In marked distinction, analysis of L5 ventral root from G85R-SOD1 +/-;VAChT-Cre +/mice showed a substantial retention of large diameter axons ( Fig. 7D) . Their axons are tightly packed, similar to control G85R-SOD1 -/-;VAChT-Cre -/- (Fig. 7A) and G85R-SOD1 -/-;VAChT-Cre +/mice ( Fig. 7B) . We measured the diameter of axons and then generated size distribution histograms by plotting the number of axons against diameter of axon subdivided into bins. L5 roots from G85R-SOD1 -/-;VAChT-Cre -/animals showed a clear separation of the histograms into two peaks ( Fig. 7E) . One peak of myelinated fibers is at between 1 and 2 m diameter (likely represents the axons from -motor neurons) and a second peak is in the range 5-10 m (likely represents -motor neuron axons) ( Fig. 7E) . Elimination of TrkB alone has no effect on axon morphology (Fig. 7B&F) . The histograms were shifted to the left, and the total number of large myelinated axons was reduced in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 7C&G) . In G85R-SOD1 +/-;VAChT-Cre +/mice there were two clear peaks with similar size range to G85R-SOD1 -/-;VAChT-Cre -/-10 animal ( Fig. 7H) . We counted the remaining axons from L5 ventral roots in three G85R-SOD1 -/-;VAChT-Cre -/mice, three G85R-SOD1 +/-;VAChT-Cre -/mice and six G85R-SOD1 +/-;VAChT-Cre +/mice, and found that there was a significant reduction of large axons (diameter  4m) in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 7I, 34519 for G85R-SOD1 +/-;VAChT-Cre -/-, 71714 for G85R-SOD1 -/-;VAChT-Cre -/mice, p<0.001). Significant preservation of large axons (diameter 4m) in L5 ventral roots was seen in G85R-SOD1 +/-;VAChT-Cre +/mice in comparison with G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 7I, 552104, p=0.0039). There is no alteration in the number of small diameter axons (4m) in L5 ventral roots ( Fig. 7J) . Examination of L5 ventral roots from 9-month-old animals showed less than 1% of large diameter axons underwent degeneration in both G85R-SOD1 +/-;VAChT-Cre -/and G85R-SOD1 +/-;VAChT-Cre +/mice ( Fig. 7K, L) . These results indicate that elimination of TrkB from motor neurons in mutant SOD1 mice delays large diameter putative -motor neuron axon degeneration.
Elimination of TrkB reduces denervation of neuromuscular junctions in G85R SOD1 mice
Finally we examined the neuromuscular junctions in gastrocnemius, extensor digitorum longus (EDL) and soleus from 10-month-old animals by immunofluorescence labeling. We found that more than 95% of endplates were innervated in gastrocnemius, EDL and soleus of G85R-SOD1 -/-;VAChT-Cre -/control mice ( Fig. 8A-C , J-L). There was no evidence of NMJ denervation in G85R-SOD1 -/-;VAChT-Cre +/animals (data not shown). At this age, we found denervation of endplates was 45.9%7.7, 48.7%3.8 and 39.4%8.2 for gastrocnemius, EDL and soleus respectively in G85R-SOD1 +/-;VAChT-Cre -/mice ( Fig. 8D-F , J-L), and in G85R-SOD1 +/-;VAChT-Cre +/mice denervation of endplates in gastrocnemius, EDL and soleus was significantly reduced (24%6.2 for gastrocnemius, 32%2% for EDL and 19%5 for soleus) ( Fig. 8G-I, J-L) . These results indicate that elimination of TrkB from adult motor neurons in mutant SOD1 mice is associated with preservation of neuromuscular junction structure.
VAChT-Cre reduces TrkB in pre-ganglionic sympathetic neurons
In addition to motor neurons, the pre-ganglionic sympathetic neurons in the intermediolateral (IML) column of the thoracic spinal cord are cholinergic. The sympathetic nervous system controls many biological processes including energy expenditure. This is of interest because mutant SOD1 mice have a hypermetabolic phenotype (35) and part of the control of resting energy expenditure (REE) is mediated by the sympathetic nervous system (36) . Pre-ganglionic sympathetic neurons regulate REE through the melanocortin 4 receptor (MC4R) (37) and BDNF/TrkB can be a downstream effector of MC4R signaling (38) . These observations raise the possibility that VAChT-Cre mediated elimination of TrkB from preganglionic sympathetic neurons might correct the metabolic defect in the mutant SOD1 mice and be the basis of the beneficial effects we have described above. In light of this we asked if VAChT-Cre was expressed in pre-ganglionic sympathetic neurons. We bred VAChT-Cre mice to the ROSA26-LacZ reporter mice, and performed X-gal histochemistry on slices of thoracic spinal cord. In 2-month old animals we found no cell labeling in the IML (data not shown) -this is consistent with the original observations of Misawa et al (29) . However, when we looked at 8-month old animals, intense labeling of cells was evident in the IML of the thoracic spinal cord (Fig. 9A) . Based on location and polygonal shape, these cells are putative pre-ganglionic sympathetic neurons.
To determine if pre-ganglionic sympathetic neurons express TrkB and if Cre recombinase can lead to its ablation, we performed laser captured single cell RT-PCR of cells in the IML column ( Fig. 9B-D) .
Analyses of sixty cells led to the identification of six that were cholinergic (i.e. they expressed ChAT) ( Fig. 9D, lanes 2, 4, 5 , 6, 7, 10). Of these six cells, five expressed Cre (Fig. 9D, lanes 2, 5, 6, 7, 10 ) and four-fifths did not express TrkB (Fig. 9D, lanes 2, 5, 6, 7) . A single ChAT(+) Cre(-) cell in the IML column was TrkB(+) (Fig. 9D, lane 4) . These observations support the view that pre-ganglionic sympathetic neurons of the IML column are depleted of TrkB in our compound mice. To the extent that the hypermetabolic phenotype of mutant SOD1 mice contributes to motor neuron degeneration, it is possible that the beneficial action of eliminating TrkB from cholinergic neurons is mediated, in part, by the modulatory actions of sympathetic neurons on REE.
Discussion
In this work we show that reduction of TrkB expression by motor neurons and a subpopulation of segmental spinal cord interneurons has a beneficial effect on a mutant SOD1 mouse model of motor neuron disease. Our genetic manipulation slows the course of the disease (particularly the early phase) and maintains motor function. These effects are likely to be subserved by preservation of motor neurons and nmjs and a reduced astrocytic/inflammatory response within the spinal cord. These observations grew out of prior in vitro work implicating TrkB activation in rendering neurons vulnerable to certain insults (18) . To our knowledge this is the first and only in vivo demonstration that reducing TrkB function can have beneficial effects in any neurodegenerative disease.
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The effects we see of reducing motor neuron TrkB expression on mutant SOD1 disease are reasonably comparable with many studies in the literature. Extending survival for 28 days is greater than 13 days offered by anti-CD40L treatment (39) or by inactivation of NADPH oxidase (40), 16 days by transplantation-based astrocyte replacement (41), 11 days by retrograde viral delivery of GDNF (42) , but less than 60 days offered by diminishing mutant SOD1 expression in astrocytes (28) , 37days by IGF-1 treatment (42) or 64 days by ablation mutant SOD1 in progenitors of motor and dorsal root ganglion neurons (33) . Similar trends are seen when one frames the results as difference between the experimental group and control as a percent of maximum life span. While there is a clear beneficial effect of eliminating TrkB from motor neurons in the mutant SOD1 mice, why is the effect relatively modest?
First, we are at the mercy of the expression of Cre from the VAChT promoter, thus the timing of the recombination event is uncontrolled. This is significant because several studies demonstrate morphological and molecular alterations in motor neurons are present early in the disease processmonth(s) before the first overt behavioral abnormality can be found (43, 44) . It is conceivable that TrkB elimination earlier in the disease process would reap a greater benefit. Second, only a subpopulation of motor neurons both expresses Cre and has deletion of the TrkB loxP allele. One could reasonably postulate that if more motor neurons lacked TrkB, the beneficial effects would be greater. Third, we do not know if elimination of TrkB function from other cells besides motor neurons might be important for the neuroprotective activity. It is generally agreed that motor neuron death in the SOD1 model is non-cell autonomous; mutant SOD1 expression in astrocytes and microglia contributes to motor neuron death (33, 45) . Although there is no evidence that astrocytes/microglia express TrkB (46, 47) , TrkB is expressed by interneurons in the adult spinal cord (46, 48) . The importance of antagonizing interneuronal TrkB is unknown. Future studies need to address these important issues.
By what mechanism(s) does elimination of TrkB benefit motor neurons in the mutant SOD1 Our in vitro studies of motor neurons grown in compartment cultures indicate that susceptibility to mutant SOD1 toxicity depends on activation of TrkB on axons or dendrites. We also found that the baleful actions of TrkB required de novo protein synthesis (51) . BDNF /TrkB signaling is known to induce translation of hundreds of mRNAs (52, 53) . One set of genes of particular interest (whose expression is induced by BDNF) is the NADPH oxidase subunits, gp91 phox , p22 phox , p47 phox and p67 phox (54) . NADPH oxidase catalyzes the production of reactive oxygen species and genetic deletion of NADPH oxidase subunits in the mutant SOD1 animal is strongly neuroprotective (40, 55) . We propose that BDNF induces the expression of a substantial panel of proteins that together is responsible for the "susceptibility-to insult" effect.
Mutant SOD1 mice are hypermetabolic as assessed by indirect calorimetry (35) and the same has been observed in a subpopulation of sporadic ALS patients (56, 57). Weight loss and low body fat in the mutant SOD1 mice can not be accounted for on the basis of fever, hyperthyroidism or hyperactivity.
These animals eat more than controls, yet lose body weight and are ketotic late in the disease. While the origin of the hypermetabolic phenotype is not well understood, it is likely to make an important contribution to the disease. One method for re-establishing balance in the energy-intake versus energyutilization equilibrium is by providing more fuel and in fact, provision of a high calorie diet extends the life of the mutant SOD1 mice (35) . An alternative approach is to reduce REE and here MC4Rs are key.
MC4Rs are expressed by subpopulations of neurons in the hypothalamus, brain stem and IML of the thoracic spinal cord (58) . MC4R -/mice are severely obese (59) and genetic replacement studies implicate MC4R expressing pre-ganglionic sympathetic neurons in controlling REE (37) . In the hypothalamus, BDNF/TrkB signaling has been shown to be a downstream effector of MC4R's control of metabolism (38) . If BDNF/TrkB signaling was an important downstream effector of MC4Rs in the pre-ganglionic sympathetic neurons, then loss of TrkB (as we found) might inhibit REE. The only data we have on this point is that G85R-SOD1 +/-;VAChT-Cre +/mice are not statistically significantly heavier than G85R- BDNF/TrkB signaling plays a critical role in the acquisition and maturation of the most advanced features of neuronal operation. Its effects on activity-dependent modification of synapses and dendritic structure underlie the nuanced interaction of an organism with its environment. We suggest that BDNF/TrkB mediated events also create a fertile substrate upon which proteotoxic events play out in neurodegeneration.
Materials and methods
Antibodies and Western blot
Antibodies used in immunostaining and immunoblot were anti-human SOD1 (ab52950, Abcam), anti- (specific for human SOD1), 5'-GCT AAC TCA GGA GCT GGC ATA-3' (specific for mouse SOD1) and 5'-CAG CAG TCA CAT TGC CCA GGT CTC CA-3' (for human and mouse SOD1). The primer set for TrkB was 5'-CCA AGG TGA TCA ACA GCC CAA GTC-3' and 5'-CCT TGA TGA TGG TTG CAC CCA CAC-3'.
Analysis of disease onset and survival
All animals we used were age and sex matched. Beginning at 30 weeks, all animals were assessed weekly with a set of behavioral tests (body weight, rotarod test, grip strength) in randomized order. Disease onset was determined as the time when mice reached their peak of bodyweight before denervation-induced muscle atrophy and weight loss. Onset of paralysis was defined as irreversible 30% drop of grip strength.
End-stage was defined as the time at which mouse could not right itself within 30 seconds when placed on its side. The survival data was analyzed by the Kaplan-Meyer life span test using MedCalc software.
Rotarod
Each mouse was trained on the rotating beam (diameter 3.5cm) of a rotarod apparatus (Columbia Instruments, Ohio) for 2 minutes before experiment. Then the time for which each mouse could remain on the rotating beam set to accelerate at 0.2 rpm/s was measured. Each animal was given three tries and the longest latency to fall was recorded.
Grip strength
The digital grip strength meter (Columbus Instruments, Ohio) was used to measure the strength of foreand hindlimbs of mice. Each animal was tested five times at a single age and the three maximum values 
Immunohistochemistry and evaluation of gliosis
Mice were sacrificed at the indicated ages, perfused with 4% paraformaldehyde and spinal cords were dissected. After postfixation in 4% paraformaldehyde for 2 hr, spinal cords were sectioned at 50 m. For immunohistochemistry, sections were incubated with 0.3% Triton X-100 for 1 hr and blocked in buffers containing 5% goat or horse serum and 1% BSA. Then sections were incubated with primary antibodies overnight at cold room. After washes, sections were incubated with fluorescence-labeled secondary antibody for 1.5 hr. For ABC method, sections were treated with 1% H 2 O 2 for 30 min to inactivated endogenous peroxidase prior primary antibody incubation. After primary antibody incubation, sections were incubated with biotinylated secondary antibody (Vector Laboratories, Burlingame, CA). Staining was developed by incubation in ABC complex (Vectastain ABC Kit; Vector Laboratories) followed by incubation in DAB solution.
Laser capture microscopy
Single cell isolation from frozen spinal cord tissue was performed with a Positioning Ablation Laser Micromanipulation (PALM) system (Carl Zeiss MicroImaging GmbH). Frozen lumbar spinal cord was first sectioned at 7 m thickness and transfer to MembraneSlide NF 1.0 PEN (Carl Zeiss). Then slides were treated with 95%, 75% and 50% of ethanol for 30 seconds respectively. After stained with Neutral Red or Hematoxylin & Eosin Y solution for 40 seconds, slides were dehydrated in 50%, 75%, 95%, 2x 100% ethanol (30 seconds each step) and two times in xylene (5min). Large motor neurons in the anterior horn were dissected from each slide. Each neuron was collected into single 0.5ml Eppendorf tube containing 50l of Buffer RLT (Qiagen). All samples were kept at -80C until use.
Single cell RT-PCR and nested PCR
Total RNA was extracted from microdissected spinal cord neurons using RNeasy Micro Kit (Qiagen) and 
Neuromuscular junction analysis
To study the NMJ, gastrocnemius, extensor digitorum longus and soleus muscles were quickly dissected, Some neuromuscular junctions showed partial overlap between endplate and terminal. These were also labeled as ''denervated''. Five mice from each experimental group (G85R-SOD1 + ;VAChT-Creand G85R-SOD1 + ;VAChT-Cre + ) were quantified.
Quantification of motor axon degeneration
After perfusion with 2% paraformaldehyde/2% glutaraldehyde, L4 and L5 roots were dissected and postfixed in the same fixatives for 4 hr. Subsequently tissues were incubated in 1% osmium tetroxide in 0.1M phosphate buffer for 1 hr, washed with PB and dehydrated in series of ethanol. Ventral and dorsal roots were then treated twice with propylene oxide for 5min, incubated sequentially with Embed 812:propylene oxide mixtures (1:1 and 2:1) and pure Embed 812 mixture (Electron Microscopy Sciences) overnight.
Tissues were then embedded in fresh Embed 812 mixture at 60C for 48 hr. Cross-sections of the roots were cut at a thickness of 1 m, stained with toludine blue and examined by light microscopy.
Measurements of large (4 m) and small (4 m) axon numbers and calibers were made with Image-Pro 
